Huang Xingfu, Chen Yanjia, Xiao Junhui, Zhao Hongxin, Chen Yizhen, Liu Shenrong, He Liwei, Huang Zheng, Zhou Haobin, Xu Dingli, Peng Jian
Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Clin Cardiol. 2018 Jan;41(1):74-80. doi: 10.1002/clc.22853. Epub 2018 Jan 25.
We aimed to explore electrophysiological characteristics of premature atrial contractions (PACs) originating from pulmonary veins (PVs) and non-PVs and to evaluate the effectiveness and safety of catheter ablation for PACs.
Symptomatic PACs originated from different positions and whether could be ablated.
Symptomatic, frequent, and drug-refractory PAC patients were enrolled in this study. All patients underwent electrophysiological study and catheter ablation.
A total of 81 patients were enrolled: 45 patients with PACs originating from PVs (group A), 24 patients with PACs originating from non-PVs (group B), and 12 patients with PACs arising from both PVs and non-PVs (group C). Twenty (44.4%) patients in group A, 6 (50.0%) patients in group C, and 3 (12.5%) patients in group B presented paroxysmal atrial fibrillation (P < 0.05). PV isolation was performed in groups A and C. Focal ablation or superior vena cava isolation was performed in groups B and C, depending on patient condition. PACs were abolished in all patients except one patient in group B. During a median follow-up period of 21.3 ± 14.3 months, 40 (88.9%) patients in group A, 10 (83.3%) patients in group C, and 21 (87.5%) patients in group B were free of recurrence after initial ablation.
Frequent PACs originating from PVs were associated with increased incidence of atrial fibrillation compared with PACs originating from non-PVs. Catheter ablation yields a satisfactory success rate and could be a good choice for eliminating symptomatic, frequent, and drug-refractory PACs.
我们旨在探究源自肺静脉(PVs)和非肺静脉的房性早搏(PACs)的电生理特征,并评估导管消融治疗PACs的有效性和安全性。
有症状的PACs起源于不同位置以及是否可被消融。
有症状、频发且药物难治性的PAC患者纳入本研究。所有患者均接受电生理检查和导管消融。
共纳入81例患者:45例PACs起源于肺静脉的患者(A组),24例PACs起源于非肺静脉的患者(B组),12例PACs同时起源于肺静脉和非肺静脉的患者(C组)。A组20例(44.4%)患者、C组6例(50.0%)患者和B组3例(12.5%)患者出现阵发性房颤(P<0.05)。A组和C组进行肺静脉隔离。B组和C组根据患者情况进行局灶消融或上腔静脉隔离。除B组1例患者外,所有患者的PACs均被消除。在中位随访期21.3±14.3个月期间,A组40例(88.9%)患者、C组10例(83.3%)患者和B组21例(87.5%)患者在初次消融后无复发。
与起源于非肺静脉的PACs相比,起源于肺静脉的频发PACs与房颤发生率增加相关。导管消融成功率令人满意,可能是消除有症状、频发且药物难治性PACs的良好选择。